Panadiplon (previously known as U-78875) was investigated as a compound with a high affinity for the benzodiazepine receptors. It was studied as a unique anxiolytic agent with a minimum of central nervous system depression for the treatment of anxiety disorders. However, panadiplon was dropped from clinical development due to unexpected hepatic toxicity in human volunteers. It was shown that the drug-induced mitochondrial dysfunction in the liver, and suggested that this dysfunction could be attributed to the carboxylic acid metabolite.

Carbendazim is a broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities widely used as a fungicide in agriculture and home gardening, and as an antihelminthic in veterinary medicine. As a fungicide, carbendazim used for controls Ascomycetes, Fungi Imperfecti, and Basidiomycetes on a wide variety of crops, including bananas, cereals, cotton, fruits, grapes, mushrooms, ornamentals, peanuts, sugarbeet, soybeans, tobacco, and vegetables. Carbendazim is a chemically stable and relatively persistent fungicide which only metabolizes to a limited extent in plants and in soil. The only detected metabolite is 2-aminobenzimidazole, which constitutes less than 5% of the total residues in leaves. Carbendazim may be anticipated to metabolize in the animal into hydroxylated analogues which may appear in meat and milk products. Carbendazim acts as a mitotic poison by altering tubulin binding and microtubule formation. This has been proposed as a possible mechanism of action for the developmental abnormalities seen in animal studies with high concentrations.

Enciprazine also known as WY-48624 or, D-3112 is a GABA A receptor agonist which was in the phase III of clinical trial for the treatment of anxiety disorders. Enciprazine was well tolerated, with low levels of sedative and asthenic side effects reported. However, research was discontinued.

Alemcinal (ABT-229), a 12-deoxymotilide, is a potent motilin agonist stereoselectively designed by Abbott researchers as an orally active gastroprokinetic agent. ABT-229 is selective agonist of the motilin receptor. ABT-229 is a synthetic derivative of erythromycin with no antibiotic activity, it has been shown to bind to motilin receptors and stimulate contractile activity of the antrum and small intestine. However, the development of Alemcinal was discontinued.

Lotrifen is a non-hormonal abortifacient agent. It is used in veterinary. Lotrifen causes the arrest and involution of pregnancy. It acts, after the implantation of the blastocyst, directly on the product of conception, which undergoes a slow and gradual degenerative process and ends with the reabsorption or expulsion of it.

Hepzidine (BS 7051) is a compound, possessing antidepressive and anticholinergic properties.

Pirmagrel is the selective thromboxane synthetase inhibitor. The compound was well tolerated by all subjects without evidence of any adverse reactions. Serum thromboxane B2 levels (the stable metabolic product of thromboxane A2) were significantly reduced after administration of the compound, with the maximal effect of a 99 per cent reduction occurring at 0.5 and 1 hour after administration. Bleeding times showed a slight increase 2 hours after administration of the compound. Pirmagrel was able to completely prevent the increase in serum thromboxane B2 following allergen challenge in asthmatic patients; while it caused a very small reduction in the early response to allergen, there was no effect on the late response or on airway hyperresponsiveness. Pirmagrel was developed for the treatment of ischemic heart disorders and thrombosis. However, this development was discontinued.

Estrazinol is a synthetic estrogen.